Sr One Capital Management, LP Crispr Therapeutics Ag Transaction History
Sr One Capital Management, LP
- $269 Million
- Q4 2024
A detailed history of Sr One Capital Management, LP transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Sr One Capital Management, LP holds 1,048,951 shares of CRSP stock, worth $43.2 Million. This represents 15.37% of its overall portfolio holdings.
Number of Shares
1,048,951
Previous 1,048,951
-0.0%
Holding current value
$43.2 Million
Previous $49.3 Million
16.24%
% of portfolio
15.37%
Previous 16.68%
Shares
1 transactions
Others Institutions Holding CRSP
# of Institutions
488Shares Held
64.1MCall Options Held
1.64MPut Options Held
1.93M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl8.97MShares$370 Million3.09% of portfolio
-
Capital International Investors Los Angeles, CA8.74MShares$360 Million0.07% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.81MShares$157 Million0.09% of portfolio
-
Black Rock Inc. New York, NY2.78MShares$115 Million0.0% of portfolio
-
Nikko Asset Management Americas, Inc.2.75MShares$113 Million1.21% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $3.22B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....